Zhenyu Zhang

发表

Glioma groups classified by IDH and TERT promoter mutations remain stable among primary and recurrent gliomas.

Y. Liu, H. Ng, Liangfu Zhou, 2017, Neuro-oncology.

Differences in the prognostic value of tumor extent of resection among the molecular subgroups of medulloblastoma:A single centre study of 113 cases

Y. Wang, H. Ng, P. Zhong, 2017 .

Differences in the Prognostic Value of Tumor Extent of Resection among the Molecular Subgroups of Medulloblastoma: A Single Centre Study of 113 Cases

Y. Wang, H. Ng, P. Zhong, 2017 .

Giant cell tumors of the skull: a series of 18 cases and review of the literature

P. Zhong, Yu Yao, Shuguang Chu, 2013, Journal of Neuro-Oncology.

TERT promoter mutations contribute to subset prognostication of lower-grade gliomas

Zhifeng Shi, Kay Ka-Wai Li, Ho-Keung Ng, 2015, Modern Pathology.

Combination genetic signature stratifies lower-grade gliomas better than histological grade

Zhifeng Shi, W. Poon, H. Ng, 2015, Oncotarget.

Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation

Y. Mao, Yin Wang, K. Li, 2016, Medical Oncology.

Clinical features of intracranial vestibular schwannomas.

Liangfu Zhou, Mingyu Chen, P. Zhong, 2013, Oncology letters.

Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer

K. Nan, Jun Chen, Xuehong Meng, 2016, Oncotarget.